Caroline experienced significant improvement overnight with her oxygen levels, and her lungs were clear when she woke up, so we were able to be discharged this afternoon. The year is already off to a great start!
Next steps: Caroline has clinic appointments, daily shots and numerous oral medications between now and her next admission for Round 4 of Immunotherapy, which is scheduled for mid-January. As always, we will keep you posted on this blog. Thank you so, so much for the continued thoughts and prayers. Happy 2019!
The Lantz Family
#carolinestrong
#ftgf
November 2017: diagnosed with Stage IV, High-Risk Neuroblastoma; Nov 2017-April 2019: completed standard treatment protocol / no evidence of disease; April 2019-April 2021: enrolled in/completed DFMO clinical trial; April 2022: RELAPSE; April 2022-June 2023: completed relapse treatment protocol / no evidence of disease (again); June 2023-June 2024: enrolled in “compassionate use” high-dose DFMO clinical trial; June 2024: RELAPSE #2
Such great news. Happy New Year to you all
ReplyDelete